Influence of dietary zinc on lead toxicity in the rat.
An investigation of the influence of dietary zinc (8, 35, 200 ppm) on the toxicity of dietary lead (0, 50, 200 ppm) in the young male rat in a seven week period indicated that as dietary zinc increased, the severity of lead toxicity decreased. Evidence included decreased lead concentration in blood, liver, kidneys, and tibias; decreased excretion of urinary delta-aminolevulinic acid; decreased accumulation of free erythrocyte porphyrins; decreased inhibition of kidney delta-aminolevulinic acid dehydrase activity; and a decrease in apparent lead absorption. Infected zinc did not afford protection against lead toxicity. The data indicate that the protective effect of zinc on lead toxicity is largely mediated by an inhibition of lead absorption at the intestinal level.
D000284:Administration, Oral; D000622:Aminolevulinic Acid / Q000652:urine; D000818:Animals; D001842:Bone and Bones / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007408:Intestinal Absorption / Q000187:drug effects; D007668:Kidney / Q000378:metabolism; D007854:Lead / Q000378:metabolism*; D007855:Lead Poisoning / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008297:Male; D000623:Porphobilinogen Synthase / Q000378:metabolism; D011166:Porphyrins / Q000097:blood; D051381:Rats; D015032:Zinc / Q000008:administration & dosage / Q000494:pharmacology*
D011166:Porphyrins; D007854:Lead; D000622:Aminolevulinic Acid; D000623:Porphobilinogen Synthase; D015032:Zinc